The University of Chicago Header Logo

Connection

Nicholas Ollberding to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Nicholas Ollberding has written about Antibodies, Monoclonal, Humanized.
Nicholas Ollberding
Connection Strength
0.034
Antibodies, Monoclonal, Humanized
  1. Real world population pharmacokinetic study in children and young adults with inflammatory bowel disease discovers novel blood and stool microbial predictors of vedolizumab clearance. Aliment Pharmacol Ther. 2023 03; 57(5):524-539.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.